January Social Media Round-Up—Celebrating 175, Discussing AI, and Attending CES 2024

image of Forture award, world's most admired companies 2023

One month into the new year and Pfizer is already got plenty to show for it.

January’s social media round-up features a dispatch from Las Vegas’s CES conference, our CTO’s insight into artificial intelligence’s impact on cancer, and an impassioned pleas from our CEO.

Catch up below:

CEO Albert Bourla kicks off Pfizer’s 175th anniversary celebration:

https://www.linkedin.com/posts/albert-bourla_2024-marks-a-significant-year-for-pfizer-activity-7150126029393580032-ES_A?utm_source=share&utm_medium=member_desktop

Chief People Experience Office Payal Sahni Becker celebrates Pfizer’s inclusion on Fortune’s Most Admired Companies list:

https://www.linkedin.com/feed/update/urn:li:activity:7159211335610699776/

CEO Albert Bourla TIME Op-Ed urging action for Israeli hostages in Gaza:

https://www.linkedin.com/posts/albert-bourla_column-my-call-to-action-for-the-israeli-activity-7155195894412230656-x3i4?utm_source=share&utm_medium=member_desktop

Chief Marketing Officer Drew Panayiotou reports back on his experience at CES 2024:

https://www.linkedin.com/posts/drewpanayiotou_ces2024-ai-activity-7151732623998930944-45mi

CEO Albert Bourla lists some of the company’s 2023 highlights:

https://www.linkedin.com/posts/albert-bourla_pfizerproud-activity-7158185661068427266-WWcI

Chief Digital and Technology Officer Lidia Fonseca shares her discussion with Forbes about AI’s impact on healthcare and the future of cancer treatment:

https://www.linkedin.com/feed/update/urn:li:activity:7159219986593386496

April Social Media Round-Up—Trailblazer Cancer Research Grants, World Health Day, and More

April has come to a close and we are barreling towards the summer. Before you head outside to enjoy spring, take a moment to catch up with Pfizer’s social channels, which have been on fire. Check out updates across our channels.

April Social Media Round-Up—Trailblazer Cancer Research Grants, World Health Day, and More

How Biomarker Testing Helped a Lung Cancer Patient Get the Treatment She Needed

Earlier this month, Science Will Win, Pfizer’s award-winning podcast, wrapped up another successful season. In the second episode of the season, which explored biomarkers and precision medicine’s role in cancer diagnosis and treatment, Dr. Raven sat down with Kelly Huffman, a longtime healthcare professional, former nurse, and Pfizer employee whose life changed a few days before Christmas 2022.

How Biomarker Testing Helped a Lung Cancer Patient Get the Treatment She Needed

Science Will Win season finale explores AI in cancer care with Pfizer Chief Oncology Officer Jeff Legos

In February, Pfizer launched the sixth season of Science Will Win, our flagship podcast which recently reached 3 million downloads. The season finale focuses on the future of technology and artificial intelligence (AI) —and what they could mean for cancer research and care.

Science Will Win season finale explores AI in cancer care with Pfizer Chief Oncology Officer Jeff Legos

March Social Media Round-Up—2025 Annual Review, World’s Most Ethical Companies, and More

Spring has sprung! At Pfizer, we’re celebrating the changing seasons with exciting updates across our social channels. Catch up on other updates.

March Social Media Round-Up—2025 Annual Review, World’s Most Ethical Companies, and More

Spring has sprung! At Pfizer, we’re celebrating the changing seasons with exciting updates across our social channels. Catch up on other updates.

Pfizer Among World’s Most Ethical Companies for 5th Straight Year

We are proud to share some news: for the fifth straight year, Pfizer has been recognized as one of the World’s Most Ethical Companies®. This recognition from Ethisphere reflects our continued commitment to integrity, transparency, and doing what’s right for patients, partners, and society.